SEMULOPARIN FOR THE EXTENDED PREVENTION OF A MORTALITY AND/OR MORBIDITY EVENT IN A PATIENT HAVING UNDERGONE HIP FRACTURE SURGERY

• 收藏
• 分享

专利权人:

AVENTIS PHARMA S.A.

发明人:

Dominique DESTREE,Francesca LAWSON

申请号：

US13712445

公开号：

US20130101524A1

申请日:

2012.12.12

申请国别(地区):

US

年份:

2013

代理人:

摘要：

The invention relates to the use of semuloparin or a pharmaceutically acceptable salt thereof for the extended prevention of a mortality and/or morbidity event, more specifically venous thromboembolism and death, in a patient having undergone hip fracture surgery.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/